| 88.90 Delayed Data As of Nov 20 |  +0.96 / +1.09%Today’s Change | 57.00 Today|||52-Week Range 90.00 | +39.80% Year-to-Date |
| Here's Why Kadmon Holdings Stock Jumped Today Nov 12 / MotleyFool.com - Paid Partner Content | Here's Why Incyte Corporation Jumped 13.0% in October Nov 07 / MotleyFool.com - Paid Partner Content |
| Previous close | 87.94 |
| Today’s open | 87.73 |
| Day’s range | 87.22 - 90.00 |
| Volume | 1,673,221 |
| Average volume (3 months) | 1,101,499 |
| Market cap | $18.7B |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +276.11% |
| Earnings growth (next 5 years) | +32.00% |
| Revenue growth (last year) | +22.50% |
| P/E ratio | 47.5 |
| Price/Sales | 7.29 |
| Price/Book | 9.59 |
| Today’s change | Today’s % change | |
|---|---|---|
| SGENSeattle Genetics Inc | +2.96 | +2.51% |
| ALXNAlexion Pharmaceutic... | -2.12 | -1.92% |
| GLPGGalapagos NV | +0.72 | +0.39% |
| ALNYAlnylam Pharmaceutic... | +10.28 | +10.50% |
| Next reporting date | February 14, 2020 |
| EPS forecast (this quarter) | $0.35 |
| Annual revenue (last year) | $1.9B |
| Annual profit (last year) | $109.5M |
| Net profit margin | 5.82% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Wilmington, Delaware |
